These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 2228076

  • 1. Changes in the sensitivities of dopamine receptors to chronic treatment with imipramine & haloperidol in rats.
    Pradhan N, Arunasmitha AS.
    Indian J Med Res; 1990 Aug; 92():293-7. PubMed ID: 2228076
    [Abstract] [Full Text] [Related]

  • 2. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR, Napier TC, Mueller RA.
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [Abstract] [Full Text] [Related]

  • 3. Time-dependent effects of antidepressant drugs on the low dose of apomorphine-induced locomotor hypoactivity in rats.
    Dziedzicka-Wasylewska M, Rogóz Z.
    Pol J Pharmacol; 1997 Aug; 49(5):337-43. PubMed ID: 9566033
    [Abstract] [Full Text] [Related]

  • 4. Opposite effects of low versus high dose haloperidol treatments on spontaneous and apomorphine induced motor behavior: evidence that at a very low dose haloperidol acts as an indirect dopamine agonist.
    Dias FR, de Matos LW, Sampaio Mde F, Carey RJ, Carrera MP.
    Behav Brain Res; 2012 Apr 01; 229(1):153-9. PubMed ID: 22244923
    [Abstract] [Full Text] [Related]

  • 5. Long-term administration of (-)deprenyl (selegiline), a compound which facilitates dopaminergic tone in the brain, leaves the sensitivity of dopamine receptors to apomorphine unchanged.
    Timar J, Knoll B, Knoll J.
    Arch Int Pharmacodyn Ther; 1986 Dec 01; 284(2):255-66. PubMed ID: 3103558
    [Abstract] [Full Text] [Related]

  • 6. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats].
    Minematsu N.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun 01; 15(3):247-52. PubMed ID: 7584718
    [Abstract] [Full Text] [Related]

  • 7. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J, Devanand DP, Carey RJ.
    Biol Psychiatry; 1982 Nov 01; 17(11):1289-301. PubMed ID: 6891268
    [Abstract] [Full Text] [Related]

  • 8. The responsiveness of the endogenous inhibitor of cAMP-dependent protein kinase to apomorphine in rat striatum after prolonged treatment with nomifensin.
    Szmigielski A, Szmigielska H, Zalewska J.
    Pol J Pharmacol Pharm; 1985 Nov 01; 37(3):285-93. PubMed ID: 4070079
    [Abstract] [Full Text] [Related]

  • 9. Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats.
    Okuyama S, Shimamura H, Hashimoto S, Aihara H.
    Arch Int Pharmacodyn Ther; 1986 Dec 01; 284(2):246-54. PubMed ID: 3827410
    [Abstract] [Full Text] [Related]

  • 10. Repeated treatment with imipramine potentiates the locomotor effect of apomorphine administered into the hippocampus in rats.
    Smiałowski A, Maj J.
    Psychopharmacology (Berl); 1985 Dec 01; 86(4):468-71. PubMed ID: 3929319
    [Abstract] [Full Text] [Related]

  • 11. Effect of supersensitivity of pre- and postsynaptic dopamine receptors on the activity of endogenous inhibitor of cAMP dependent protein kinase in rat striatum.
    Szmigielski A, Szadowska A, Szmigielska H.
    Arch Int Pharmacodyn Ther; 1984 Dec 01; 272(2):214-24. PubMed ID: 6098230
    [Abstract] [Full Text] [Related]

  • 12. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
    Ushijima I, Noda Y, Mizuki Y, Yamada M.
    Arch Int Pharmacodyn Ther; 1984 Oct 01; 271(2):180-8. PubMed ID: 6150689
    [Abstract] [Full Text] [Related]

  • 13. The effect of stimulation of pre- and postsynaptic dopamine receptors on the endogenous inhibitor of cAMP-dependent protein kinase.
    Szmigielski A, Kowner A.
    Arch Int Pharmacodyn Ther; 1984 Dec 01; 272(2):205-13. PubMed ID: 6098229
    [Abstract] [Full Text] [Related]

  • 14. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
    Feifel D, Priebe K, Johnstone-Miller E, Morgan CJ.
    Psychopharmacology (Berl); 2002 Jul 01; 162(2):138-46. PubMed ID: 12110991
    [Abstract] [Full Text] [Related]

  • 15. Role of dopamine receptors in gastrointestinal motility.
    Dhasmana KM, Banerjee AK, Zhu YN, Erdmann W, Parmar SS, Salzman SK.
    Res Commun Chem Pathol Pharmacol; 1989 Jun 01; 64(3):485-8. PubMed ID: 2571179
    [Abstract] [Full Text] [Related]

  • 16. Functional interaction between serotonin-S2 and dopamine-D2 neurotransmission as revealed by selective antagonism of hyper-reactivity to tryptamine and apomorphine.
    Awouters F, Niemegeers CJ, Megens AA, Janssen PA.
    J Pharmacol Exp Ther; 1990 Sep 01; 254(3):945-51. PubMed ID: 1697623
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of apomorphine on morphine analgesia during the state of dopaminergic supersensitivity after chronic treatment with haloperidol.
    Kamata K, Ogawa K, Noma S, Kameyama T.
    J Pharmacobiodyn; 1986 Jan 01; 9(1):88-94. PubMed ID: 3712211
    [Abstract] [Full Text] [Related]

  • 19. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
    Zharkovskiĭ AM, Matvienko OA, Nurk AM.
    Biull Eksp Biol Med; 1984 Oct 01; 98(10):444-6. PubMed ID: 6541951
    [Abstract] [Full Text] [Related]

  • 20. [Role of serotonin and dopamine receptors in the mechanism of action of haloperidol and pirenperone].
    Maĭmets MO, Vasar EE, Nurk AM, Allikmets LKh.
    Farmakol Toksikol; 1985 Oct 01; 48(2):15-8. PubMed ID: 3996566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.